Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Ossium Health, Inc.
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
Instituto Nacional de Cancer, Brazil
Roswell Park Cancer Institute
Gamida Cell ltd
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Ciusss de L'Est de l'Île de Montréal
University of Michigan Rogel Cancer Center
OHSU Knight Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Washington University School of Medicine
Singapore General Hospital
Polyphor Ltd.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Erlangen-Nürnberg Medical School
Targazyme, Inc.
National Cancer Institute (NCI)
Asan Medical Center
Washington University School of Medicine
Baylor College of Medicine
Northwestern University
Accenture
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center